6月26日,胶原蛋白龙头锦波生物宣布一项重磅融资计划,通过定向增发股票募集20亿元资金,全部由前中国首富钟睒睒控制的养生堂独家认购。这笔钱将用于两大方向,技术升级:开发“人源化胶原蛋白FAST数据库与产品平台”(用AI加速研发);资金储备:补充公司运营现金流,支撑业务扩张。为什么首富如此看好胶原蛋白?钟睒睒的投资眼光以“瞄准高毛利、大市场”著称,而胶原蛋白完美契合这两点:超高盈利能力锦波生物毛利率...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.